Exposure of animals to Perfluorooctanoic acid (PFOA), a surfactant used in emulsion polymerization processes causes early pregnancy loss, delayed growth and development of fetuses. The mechanisms of action are largely unknown. We studied the effect of PFOA on implantation using an in vitro spheroid-endometrial cell co-culture model. PFOA (10-100 µM) significantly reduced Jeg-3 spheroid attachment on RL95-2 endometrial cells. PFOA also suppressed -catenin expression in Jeg-3 cells. The Wnt agonist Wnt3a stimulated -catenin expression in Jeg-3 cells and reversed the PFOA suppression of the spheroid attachment. The putative PFOA receptors (PPAR,  ) present in both cell lines were not affected by PFOA (0.01-100 µM). The PPAR antagonist MK886 restored the -catenin and E-cadherin expression levels in Jeg-3 cells and reversed the suppression of the spheroid attachment caused by PFOA. Taken together, PFOA suppresses spheroid attachment through PPAR and Wnt signaling pathways via down-regulation of -catenin and E-cadherin expression.
Introduction
Many natural or man-made chemicals can interfere with the endocrine system leading to adverse health effects in both laboratory animals and wildlife species [1] . For example, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) can disrupt the morphogenesis of rat pre-implantation embryos [2] , reducing the numbers of implanted embryos and live-born pups [3] .
Perfluorooctanoic acid (PFOA), a known endocrine disruptor, has been used as a surfactant in emulsion polymerization processes of fluoropolymers for over 50 years.
This chemical is present in industrial waste, and has been detected in stain resistant carpets, carpet cleaning liquids, water, food, microwave popcorn bags, and house dust [4] .
Moreover, PFOA is persistent in the environment and has been shown to be toxic to laboratory animals and wildlife [5] . Notably, concentrations of PFOA as high as 3.7 ppm have been found in house dust [6] . PFOA can enter the human body by inhalation and ingestion. It binds to proteins in the blood serum and accumulates in various organs including the spleen and liver [7] . PFOA has been detected in the serum of fluorochemical production workers (691 ng/mL; range, 72-5100 ng/mL), and its half-life in blood is 3.8 years [8] . In various animal studies, PFOA was found to be associated with infertility, birth defects and increased cancer risk [4] . However, direct evidence of how PFOA affects the fertility of animals is lacking. Several acute oral toxicity studies in animals indicate that PFOA causes hepatomegaly and hepatic peroxisome proliferation [9] . Moreover, PFOA exposure increases the risk of liver, testicular and pancreatic tumors, and causes hormonal disruption and immunotoxicity [4] . Perfluorododecanoic acid, a member of the perfluorinated family of compounds, decreased serum testosterone levels but increased estradiol levels in adult rats [10] . PFOA modulated serum hormonal effects in rodents causing Leydig cell hyperplasia and adenomas [5] , and decreased the expression levels of genes involved in steroidogenesis leading to a reduced serum testosterone level [10] .
PFOA binds to the peroxisome proliferator-activated receptors (PPAR,  and ) with varying affinities modulating the downstream biological processes [11] including cellular inflammation, reproduction, lipid homeostasis and wound healing [12] . A recent study demonstrated that PPAR interacted with the canonical Wnt signaling pathway in human cholangiocarcinoma cells [13] . Increasing evidence suggests that the Wnt signaling pathway plays very important roles in embryonic development, cell differentiation and implantation [14, 15] . Activation of Wnt signaling is mediated by binding of Wnt ligands (e.g. Wnt3a) to its receptor allowing accumulation of -catenin for gene transcription and downstream biological processes. How PFOA binds to PPAR and affects the activation of the Wnt signaling pathway for embryo implantation remains largely unknown. We investigated the mechanism of action of PFOA on implantation by studying spheroid attachment using human trophoblastic spheroids (Jeg-3) and endometrial epithelial cells (RL95-2) in a co-culture assay. Because the use of human embryos and primary endometrial epithelial cells is limited, this in vitro co-culture model can mimic the initial embryo (spheroids) attachment process using well-established human cell lines. We used PPAR inhibitors to further elucidate the mechanism of PFOA/PPARs regulation of the canonical Wnt signaling molecules in both Jeg-3 and RL95-2 cells during the spheroid attachment process.
Materials and methods

Cell culture
Human choriocarcinoma Jeg-3 (HTB-36, ATCC) and endometrial adenocarcinoma RL95-2 (CRL-1671, ATCC) cells were both cultured at 37 o C in a humid atmosphere in 5% CO 2 . Cells were maintained in DMEM/F12 (Sigma, MO, USA), supplemented with 10% fetal bovine serum (FBS, Invitrogen, Carlsbad, CA, USA), 2 mM L-glutamine and penicillin/streptomycin (100 U/ml and 0.1 mg/ml) (Gibco, NY, USA). For each experiment, 1 x 10 5 cells were suspended in the cell culture medium and seeded in 12-well tissue culture plates (Iwaki, Japan). PFOA (96% purity, Sigma) was dissolved in dimethyl sulfoxide (DMSO). The Jeg-3 and RL95-2 cells were then cultured in PFOA-containing culture medium for 24 hrs prior to either Western blotting or spheroid generation for co-culture study. PFOA concentrations ranging from 0.01 to 100 µM were prepared in DMSO (0.1% final concentration) and 0.1% DMSO was used as the negative control. All treatments were repeated in duplicate at least five times. Anti-rabbit, anti-mouse (1:5000) (GE Healthcare, Pittsburgh, PA) or anti-goat antibodies (1:5000) (Santa Cruz) were used as the horseradish peroxidase-conjugated secondary antibody. The membranes were visualized by enhanced chemiluminescence (Santa Cruz).
Protein extraction and Western blotting
To normalize the protein loading, the membranes were stripped and re-blotted with anti--actin antibody (Sigma). For the cell viability assay, 2 × 10 5 cells were seeded per well in duplicate in six-well plates. Jeg-3 or RL95-2 cells were cultured for 24 hrs with different concentrations of the treatments. The treated cells were trypsinized and the cell suspension was centrifuged for 5 mins at 100 g. The cell pellet was resuspended in 500 µl of PBS containing 0.4% trypan blue. The unstained (viable) and the stained (nonviable) cells were counted using a hemacytometer. The percentage of viable cells was calculated from the total number of cells.
Cell proliferation and cell viability assay
Spheroid attachment assay
The Jeg-3 and RL95-2 cells were cultured at 37°C in a humid atmosphere in 5% CO 2 as above. Adhesion of the choriocarcinoma Jeg-3 spheroids on the endometrial RL95-2 cells was quantified using an adhesion assay as previously described [16] . inhibitors for 1 hr at 37°C in a humidified atmosphere in 5% CO 2. Non-adherent spheroids were removed by centrifugation in the medium at 10 g for 10 mins. Attached spheroids were counted under a microscope and the attachment rate was expressed as a percentage of the total number of spheroids transferred (% adhesion). Images of the cultures were taken using a Nikon Eclipse TE300 inverted microscope (Nikon, Tokyo, Japan).
Wnt signaling activation
Wnt3a conditioned medium (Wnt3a-CM) was obtained from the culture of mouse L cells stably secreting the Wnt3a protein. Briefly, mouse fibroblast L cells over-expressing Wnt3a (CRL-2647, ATCC) were cultured in DMEM medium supplemented with 10% FBS, L-glutamine and penicillin/streptomycin. The conditioned medium was collected after 48 hrs of confluent culture and the expression of Wnt3a protein was confirmed by
Western blotting using a specific anti-Wnt3a antibody. The conditioned medium obtained from normal mouse fibroblast L cells was used as the negative control for the spheroid attachment assay. All conditioned media were filter-sterilized and stored at -20 o C until used.
Statistical analysis
All results were calculated as the mean ± standard error of mean (SEM) from at least three independent experiments. All the data were analyzed using the SigmaPlot statistical software (SigmaPlot 11.0; Jandel Scientific, San Rafael, California, USA). The
Mann-Whitney U test was used when the data was not normally distributed. A p-value of less than 0.05 was considered to be statistically significant.
Results
Effect of PFOA on the expression of PPARs in trophoblastic and endometrial cell lines
The three PPAR isotypes (PPARα, PPARβ and PPARγ) have similar molecular weights but have unique structures associated with the subtype specificity. PFOA (0.01-100 µM) did not significantly change the expression of PPARα, PPARβ and PPARγ in both the Jeg-3 and RL95-2 cells as determined by Western blotting (Figure 1A & B ).
PFOA suppressed spheroid attachment onto endometrial cells
A spheroid-endometrial cell co-culture assay was used to study whether PFOA 
Effects of PPAR antagonists on PFOA suppression of the spheroid attachment
We used PPARα, PPARβ and PPARγ antagonists (MK886, GSK0660 and GW9662, respectively) to study the role of PPARs in the PFOA suppression of the -catenin expression and spheroid attachment. The concentration of the inhibitors used in this study did not affect the viability and proliferation of the treated cells (data not shown). Western blot analysis showed that PFOA strongly suppressed -catenin and E-cadherin expressions in Jeg-3 cells, and addition of Wnt3a reversed these suppressive effects.
Importantly, treatment of Jeg-3 cells with MK886 (10 µM), but not GSK0660 (10 µM) or GW9662 (1 µM), reversed the suppressive effects of PFOA on the expression of -catenin and E-cadherin ( Figure 5A ). However, PFOA did not affect the expression of -catenin and E-cadherin in the RL95-2 cells. We found that the PPAR inhibitor MK886 (10 µM) reversed the PFOA (100 µM) suppression of the spheroid attachment ( Figure   5B ), whereas the PPARγ inhibitor GW9662 (1 µM) partially reversed the suppressive effects of PFOA when compared with PFOA treatment group. No significant change was observed when the cells were treated with the PPARβ inhibitor GSK0660 (10 µM).
Discussion
The mechanism of PFOA suppression of trophoblastic spheroid attachment seems to be mainly via the down-regulation of the Wnt signaling pathway in trophoblastic cells.
The PFOA suppression of spheroid attachment was reversed by Wnt3a and the PPARα inhibitor MK886 suggesting the involvement of cross-talk between the Wnt signaling and PPAR pathways in modulating this suppressive effect.
PFOA can activate PPAR in an in vitro model system. Activation of the PPARs leads to transcription of target genes and modulation of various biological processes including energy homeostasis, lipid metabolism, cell differentiation [17] and pregnancy [18] . In the present study, both the RL95-2 and the Jeg-3 cells expressed PPARα, PPARβ and PPARγ. Although PFOA (0.01-100 µM) did not affect the expression of PPARs and cell viability in Jeg-3 and RL95-2 cells (data not shown), other studies report that PFOA at higher concentrations (50-500M) can induce cytotoxic effects and change cell cycle profiles in cells in vitro [19, 20] .
The spheroids-endometrial cells co-culture assay was used to study the attachment process in vitro [21] . Three different treatment groups (Jeg-3 cells, RL95-2 cells, and both cell lines) were used to study the effect of PFOA on the two cell lines. When both cells were treated with PFOA (10 and 100 M), the spheroid attachment rates decreased significantly. A similar suppressive effect was observed when Jeg-3 cells were treated with PFOA (100 µM), suggesting the suppressive effect of PFOA is mainly through trophoblastic cells.
The canonical Wnt signaling pathway regulates embryo implantation and early embryonic development [15, 22] . PFOA strongly suppresses -catenin and E-cadherin expression in the Jeg-3 cells, but how these changes affect spheroid attachment remains largely unknown. The expression of endometrial E-cadherin and -catenin are higher in healthy fertile women, and impaired down-regulation of endometrial E-cadherin and -catenin expression during the window of implantation is associated with infertility in patients with endometriosis [23] . In contrast, up-regulation of -catenin in the apical membrane of epithelial cells at the implantation sites was observed in mice [24] . In line with these observations, we found that Wnt3a-CM up-regulated -catenin expression in cells treated with another endocrine disruptor, TCDD [25] , or oviductal epithelial (OE-E6/E7) cells treated with a Wnt antagonist, Olfm [26] .
To determine whether PFOA interacts with PPARs to affect spheroid attachment, we used three PPAR antagonists (MK886, GSK0660 and GW9662). MK886 inhibits PPARα through a non-competitive mechanism that prevents conformational change during the active-complex formation [27] . GSK0660 is a potent PPARβ/δ antagonist [28] and GW9662 covalently modifies the cysteine residue at the binding site of PPARγ [29] . The concentrations of the PPARs antagonists used were specific for inhibiting the different PPAR receptors [28, 30, 31] . However, the effect of the specific antagonist on development and pregnancy outcome in animals remains largely unknown. Our findings showed that MK886 reversed the PFOA-induced suppression of the spheroid attachment, but GSK0660 had no reversing effect, and GW9662 could only partially reverse the effects of PFOA (100 µM) when compared with PFOA treated group. This suggests that PFOA exerts its effect mainly through the PPARα pathway. Although mice deficient in PPAR are not associated with early pregnancy lost, PPAR is required for PFOA-induced postnatal lethality [32] . Treatment with a lower concentration of PFOA (10 M) in both the Jeg-3 and RL95-2 cells affected spheroid attachment, but PFOA (10 M) with RL95-2 cells alone had no effect on -catenin expression and spheroid attachment. This suggests that PFOA may affect the expression of other molecule(s) that are important for spheroid and endometrial cells interaction in vitro.
Our The suppressive effect could be nullified by treating the cells with MK886 (10 M) but not GSK0660 (10 M). The suppressive effect could be partially nullified by GW9662 (1 M). MK886, GSK0660 or GW9662 alone had no effect on spheroid attachment. MTX 
